Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 11,056 shares at $21.42 ($237K) on 2019-05-29, disclosed to the SEC on 2019-05-30.
Open-market sale of $237k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.42 | 5,528 | $118K | 50.0% |
| 2 | $21.42 | 5,528 | $118K | 50.0% |
| Total | $21.42 avg | 11,056 | $237K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |